Scholars Central

Conference abstractPublished 2019

Baculovirus as a new stand-alone prophylactic and therapeutic immunostimulatory agent against malaria

Authors: Talha Bin Emran, Foisal Mahmud, Mitsuhiro Iyori, Shigeto Yoshida

BGC Trust University, Bangladesh University of Chittagong, Bangladesh Kanazawa University, Japan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Baculovirus (BV), which is an enveloped insect virus with a circular double-stranded DNA genome, possesses unique characteristics to induce strong innate immune responses in various mammalian cells and in mice. Aim: Here we show that the innate immune responses induced by BV not only eliminate Plasmodium liverstage parasites but also elicit sterile protection against Plasmodium sporozoite infection through type I IFN signaling pathway. Methodology: Mice had infected with liver-stage parasites before 24h completely prevented blood-stage parasites following a single dose of BV intramuscular (i.m.) administration, which was much superior to primaquine, the only drug approved to eradicate liver-stage parasites. Findings: This BV-mediated liver-stage parasite elimination was also observed in TLR-9-/-and iNOS- /- mice. In addition to the therapeutic effect, BV i.m. administration sterilely protects mice for at least 7 days from subsequence sporozoite infection, indicating the prophylactic effect. In vivo passive transfer with sera from mice i.m. administered with BV effectively eliminated liver-stage parasites and this effect was canceled by neutralization of IFN-a but not IFN-g in the sera, indicating a killing mechanism downstream of type I IFN signaling pathway. In fact, 6h after BV i.m. administration, both type I and II IFNs were robustly produced in sera and RNA transcripts of interferon-stimulated genes were drastically upregulated in the liver. Conclusion & Significance: Our results provide a great potential of BV for development of BV-based vaccine and anti-hypnozoite drug as a new stand-alone therapeutic and prophylactic immunostimulatory agent, which is applicable not only for malaria but also for other serious infectious diseases such as viral hepatitis.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cell Biology: Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCell Biology: Research & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Talha Bin Emran”
  • BylineArticles whose byline prints “Foisal Mahmud”
  • BylineArticles whose byline prints “Mitsuhiro Iyori”
  • BylineArticles whose byline prints “Shigeto Yoshida”